期刊文献+

核苷类似物治疗慢性乙型肝炎快速应答良好和快速应答不良患者的病毒学应答比较 被引量:14

原文传递
导出
摘要 慢性乙型肝炎治疗的总体目标是最大限度地长期抑制或消除HBV,减轻肝细胞炎性坏死及肝纤维化,延缓和阻止疾病进展,减少和防止肝功能失代偿、肝硬化、肝细胞癌及其并发症的发生,从而改善生活质量,延长存活时间。虽然不能彻底治愈慢性乙型肝炎,但长期抗病毒治疗可有效阻止可能导致肝功能失代偿的肝炎活动,预防进展为肝硬化和(或)肝细胞癌,最终延长患者生存期。
出处 《中华传染病杂志》 CAS CSCD 北大核心 2008年第2期103-104,共2页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献9

  • 1ter Borg MJ, van Zonneveld M, Zeuzem S, et al. Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response. Hepatology, 2006, 44:721-727.
  • 2van der Eijk AA, Niesters HG, Hansen BE, et al. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha. J Viral Hepat, 2006, 13:96-103.
  • 3Liu CJ, Lai MY, Chao YC, et al. Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study. Hepatology, 2006, 43 : 742-749.
  • 4Brouwer JT, Hansen BE, Niesters HG, et al. Early prediction of response in interferon monotherapy and in interferonribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. J Hepatol, 1999, 30: 192-198.
  • 5Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med, 2002, 347:975-982.
  • 6National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C. Hepatology, 2002, 36(5 Suppl 1):S3-S20.
  • 7NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements, 2002, 19:1-46.
  • 8de Franchis R, Hadengue A, Lau G, et al. EASL International Consensus Conference on Hepatitis B. J Hepatol, 2003, 39(Suppl 1) :S3-S25.
  • 9Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2001, 34:1225-1241.

同被引文献70

引证文献14

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部